We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
PRA Group
PRAA
$683M
| $23.8M | 0.03% |
726,141
+39,148
| +6% | +$1.46M |
|
277
Omnicom Group
OMC
$23.5B
| $23.8M | 0.03% |
376,233
-153,055
| -29% | -$10.4M |
|
278
Ingevity
NGVT
$2.59B
| $23.6M | 0.03% |
384,335
-10,214
| -3% | -$685K |
|
|
FL
279
DELISTED
Foot Locker
FL
| $23M | 0.03% |
736,230
-399,699
| -35% | -$12.8M |
|
280
Haemonetics
HAE
$3.63B
| $22.6M | 0.03% |
300,014
-9,006
| -3% | -$647K |
|
281
Sally Beauty Holdings
SBH
$1.43B
| $22.5M | 0.03% |
1,798,838
-109,650
| -6% | -$1.52M |
|
282
Charter Communications
CHTR
$15.7B
| $22.4M | 0.03% |
73,747
-4,334
| -6% | -$1.85M |
|
|
SKX
283
DELISTED
Skechers
SKX
| $22.2M | 0.03% |
686,433
-16,651
| -2% | -$623K |
|
|
UCTT
284
Ultra Clean Holdings
UCTT
$3.9B
| $22.1M | 0.03% |
826,181
-23,433
| -3% | -$717K |
|
285
Kinross Gold
KGC
$28.6B
| $21.3M | 0.03% |
4,094,211
+242,136
| +6% | +$823K |
|
|
HI
286
DELISTED
Hillenbrand
HI
| $21M | 0.03% |
550,846
-4,789
| -0.9% | -$201K |
|
287
Sotera Health
SHC
$4.92B
| $21M | 0.03% |
3,109,343
+2,203,400
| +243% | +$36.6M |
|
288
NCR Voyix
VYX
$1.13B
| $20.7M | 0.03% |
1,751,394
-46,326
| -3% | -$850K |
|
289
Gray Television
GTN
$409M
| $20.7M | 0.03% |
1,447,623
-252,895
| -15% | -$4.64M |
|
290
TTEC Holdings
TTEC
$107M
| $20.6M | 0.03% |
468,851
-9,550
| -2% | -$568K |
|
291
Wabash National
WNC
$538M
| $20.5M | 0.03% |
1,235,758
-38,495
| -3% | -$629K |
|
292
Electronic Arts
EA
$52.4B
| $20.4M | 0.03% |
175,813
-10,568
| -6% | -$1.34M |
|
|
VSXY
293
Victoria's Secret
VSXY
$6.78B
| $20.4M | 0.03% |
664,755
-14,149
| -2% | -$477K |
|
294
Preferred Bank
PFBC
$1.23B
| $20.1M | 0.03% |
300,282
+13,467
| +5% | +$940K |
|
295
Ovintiv
OVV
$16.6B
| $20.1M | 0.03% |
+315,718
| New | +$15.1M |
|
296
SouthState Bank Corp
SSB
$10.2B
| $19.8M | 0.03% |
244,588
-1,315
| -0.5% | -$106K |
|
297
Ecovyst
ECVT
$1.34B
| $19.3M | 0.03% |
2,232,021
+941,864
| +73% | +$8.95M |
|
298
Philip Morris
PM
$305B
| $19.1M | 0.03% |
230,052
-6,789
| -3% | -$647K |
|
299
Magna International
MGA
$18.3B
| $18.5M | 0.03% |
389,752
-22,548
| -5% | -$1.31M |
|
300
ManpowerGroup
MAN
$2.5B
| $18.1M | 0.03% |
279,933
-16,799
| -6% | -$1.26M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.